Baron Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$812K Buy
8,860
+1,995
+29% +$175K 0.21% 65
2026
Q1
$585K Buy
6,865
+3,360
+96% +$299K 0.18% 82
2025
Q4
$277K Sell
3,505
-2,273
-39% -$178K 0.09% 180
2025
Q3
$462K Buy
5,778
+414
+8% +$35.3K 0.15% 95
2025
Q2
$488K Buy
5,364
+2,144
+67% +$196K 0.17% 83
2025
Q1
$302K Buy
+3,220
New +$288K 0.13% 127
2024
Q4
Sell
-2,363
Closed -$245K 204
2024
Q3
$245K Buy
+2,363
New +$241K 0.12% 154

Other funds holding CL

Baron Wealth Management's CL Position: Q2 2026 in Review

Baron Wealth Management increased its Colgate-Palmolive (CL) stake by 29% in Q2 2026, buying an estimated $175K and bringing the position to 8,860 shares worth $812K. The position accounts for 0.21% of the portfolio, ranked #65.

Baron Wealth Management first reported a position in CL in Q3 2024 and has held it in 7 quarters since. 483 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Baron Wealth Management held 8,860 shares of Colgate-Palmolive worth $812K as of Q2 2026.
  • Baron Wealth Management bought 1,995 Colgate-Palmolive shares in Q2 2026, an estimated $175K.
  • Colgate-Palmolive made up 0.21% of Baron Wealth Management's portfolio in Q2 2026, its #65 holding.
  • Baron Wealth Management first reported a position in Colgate-Palmolive in Q3 2024 and has held it in 7 quarters since.
  • 483 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Baron Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.